Table 2.

Prevalence of eating disorder symptoms according to SCOFF in the prepandemic BELLA and the pandemic COPSY study, stratified by age group and gender.

	BELLAa % [CI]	COPSY % [CI]	OR [CI]
Age
11–13 years	12.56 [9.37–15.75]	14.87 [11.45–18.28]	1.23 [0.83–1.83]
14–17 years	25.94 [22.22–29.66]	17.10 [14.07–20.18]	0.59 [0.44–0.79]***
Gender
Female	31.72 [27.44–36.00]	17.18 [13.83–20.52]	0.45 [0.33–0.61]***
Male	9.35 [6.78–11.92]	15.08 [11.96–18.2]	1.75 [1.18–2.58]**
Total	20.10 [17.55–22.65]	16.20 [13.92–18.48]	0.77 [0.61–0.97]*

Prevalence estimates are based on weighted data. BELLA: n = 977; COPSY n = 993. Significant differences (p < 0.05) were examined by unadjusted logistic regressions and are indicated in boldface. CI, 95%-Confidence Interval, OR, Odds Ratio. Discrepancies to reported prevalence for KiGGS 2 (24) resulting from smaller subsample. ^aReference category. *** p ≤ 0.001; **p ≤ 0.01; *p < 0.05.